ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,538Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 1448

$700K Total Retail Price of All Prescriptions

Rank: 65 out of 1448

344 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 344 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 10,178 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 397 373 1 2
SIMVASTATIN 396 336 2 3
FUROSEMIDE 319 275 3 7
OMEPRAZOLE 317 280 4 23
LOSARTAN POTASSIUM 269 262 5 11
JANUVIA 252 226 6 64
HYDROCHLOROTHIAZIDE 249 214 7 18
DIOVAN 245 208 8 15
METFORMIN HCL 242 205 9 25
GABAPENTIN 237 221 10 51
ATORVASTATIN CALCIUM 237 219 10 4
ZOLPIDEM TARTRATE 218 184 12 34
METOPROLOL TARTRATE 216 181 13 9
HYDROCODONE-ACETAMINOPHEN 212 170 S3 14 33
POTASSIUM CHLORIDE 204 180 15 19
TAMSULOSIN HCL 190 180 16 46
DIGOXIN 182 154 17 13
GLIMEPIRIDE 167 158 18 66
ISOSORBIDE MONONITRATE ER 164 152 19 16
DONEPEZIL HCL 156 152 20 68
PANTOPRAZOLE SODIUM 148 140 21 42
CLOPIDOGREL 142 131 22 10
FENOFIBRATE 140 116 23 54
BENAZEPRIL HCL 115 94 24 26
LEVOTHYROXINE SODIUM 114 104 25 21
WARFARIN SODIUM 107 88 26 8
NAMENDA 104 100 27 93
PLAVIX 104 94 27 14
TRAMADOL HCL 99 67 29 56
SPIRONOLACTONE 97 76 30 24
MEGESTROL ACETATE 96 96 R 31 126
ACETAMINOPHEN-CODEINE 96 92 S3 31 113
DEXILANT 95 85 33 87
CARVEDILOL 92 85 34 1
LIPITOR 84 81 35 30
METOLAZONE 83 65 36 124
KLOR-CON 8 77 70 37 70
CRESTOR 77 71 37 17
FAMOTIDINE 77 62 37 60
LISINOPRIL 74 60 40 5
METOPROLOL SUCCINATE 73 72 41 6
SERTRALINE HCL 72 69 42 99
NIFEDIPINE ER 69 64 43 59
DIOVAN HCT 68 50 44 29
AMLODIPINE BESYLATE-BENAZEPRIL 67 67 45 67
HYDRALAZINE HCL 67 61 45 44
ATENOLOL 66 53 47 12
CLONIDINE HCL 65 65 48 45
MELOXICAM 64 57 49 73
JANUMET 63 62 50 119
IBUPROFEN 61 40 51 85
LOSARTAN-HYDROCHLOROTHIAZIDE 61 51 51 38
LANTUS 61 42 51 111
IBANDRONATE SODIUM 60 60 54 148
AMIODARONE HCL 60 51 54 22
NABUMETONE 55 44 56 140
ALLOPURINOL 54 54 57 43
NEXIUM 54 53 57 49
ENOXAPARIN SODIUM 51 51 59 318
RAMIPRIL 51 43 59 36
PROAIR HFA 50 41 61 104
NITROSTAT 50 44 61 31
FLUTICASONE PROPIONATE 50 48 61 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.